Table 1 in Prevalence and genotyping of Pneumocystis jirovecii in renal transplant recipients-preliminary report

Table 1 Comparison of Pneumocystis jirovecii -positive and Pneumocystis jirovecii - negative patients’ basic characteristics Pneumocystis jiroveciiCharacteristicPositive (n = 8)Negative (n = 64)P valueAge in years, mean (range)55.1 (35–69)52.2 (21–76)0.292SexMale6 (75)30 (46.9)0.260Female2 (25)34 (53.1)0.260Time after kidney transplantation in months, mean (range)68.2 (4.7–142.5)80 (0.16–225.6)0.080Kidney transplantation episodeFirst7 (87.5)54 (84.4)1.000Second1 (12.5)8 (12.5)1.000Third–2 (3.1)1.000Symptoms3 (26.5)17 (37.5)0.676Dyspnea1 (12.5)5 (7.8)0.520Fever1 (12.5)12 (18.75)1.000Unproductive cough1 (12.5)6 (9.4)0.578Ongoing prophylaxis2 (25)12 (18.75)0.648Immunosuppressive regimenCI, prednisone, MMF2 (25)37 (57.8)0.131CI, prednisone, AZA–4 (6.2)1.000PSI, prednisone, MMF–1 (1.6)1.000PSI, prednisone–1 (1.6)1.000CI, prednisone5 (62.5)16 (25)0.041*CI, MMF–3 (4.7)0.301Prednisone1 (12.5)2 (3.1)1.000Other potential risk factorsCMV infection1 (12.5)10 (15.6)1.000Eosinophils/μl, mean (range)a74 (0–250)272 (0–7200)0.040*CRP mg/l, mean (range) b32.1 (0.3–176.3)42.3 (0.2–468)0.144